Cooper and Inspira Cardiac Care is First in the Region to Treat AFib With Innovative Tissue-Sparing FARAPULSE™ PFA System

George A. Mark, MD, FACC, center, celebrates the successful launch of the FARAPULSE™ PFA System with the interventional cardiology team.

(CAMDEN, NJ) – A team of interventional cardiologists with Cooper and Inspira Cardiac Care is the first in the region, and one of very few in the country, to use the FARAPULSE™ PFA System by Boston Scientific for treatment of atrial fibrillation (AFib), or an irregular or rapid heart rhythm. FARAPULSE™ uses ultra-rapid electrical pulses, called pulsed field ablation (PFA), to treat AFib versus traditional radiofrequency (RF) or cryothermal ablation. This technology was FDA approved in January of this year.

George A. Mark, MD, FACC, and John Costello, DO, FACC, members of the medical staffs at both Cooper University Health Care and Inspira Health, were part of a multidisciplinary team led by Andrea Russo, MD, FACC, FHRS, FAHA, Director of Electrophysiology and Arrhythmia Services at Cooper and member provider of Cooper and Inspira Cardiac Care, to perform the inaugural cases at Cooper University Hospital in Camden.

The FARAPULSE system has five splines with four electrodes, each providing energy delivery to the treatment area, resulting in shorter procedural time and less risk for the patient. The system allows for more accurate targeting of heart tissue with less vulnerability for surrounding tissues, minimizing risks.

“Not only are we proud to be offering FARAPULSE™ PFA System at Cooper and Inspira Cardiac Care, but we are also excited that Cooper is the first hospital in the South Jersey and the Philadelphia area to make this revolutionary treatment option available for patients with AFib,” Dr. Russo said. “FARAPULSE™ PFA System has the capability to help patients with AFib and improve quality of life. Patients have been asking for a solution and I am excited to offer this safer, more efficient modality to them.”

According to the American Heart Association, atrial fibrillation affects between 2.7 and 6.1 million Americans, often leading to heart-related complications as well as increasing the risk for stroke fivefold. For patients with AFib who are unable to take blood thinners long-term, the efficiency of PFA significantly improves efficiency and safety for patients.

About Cooper and Inspira Cardiac Care

Cooper and Inspira Cardiac Care brings together the leading cardiology practices and innovative health care systems of two large medical providers: Cooper University Health Care and Inspira Health. The combination of the two makes Cooper and Inspira Cardiac Care the largest cardiac program in South Jersey, providing patients in the region with access to more coordinated cardiac services across the continuum of care. To learn more, visit


Leave a Reply

DO NOT USE THIS FORM FOR APPOINTMENTS. Using this form will only delay your ability to get an appointment. Please use the contact information in the article or visit